Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Hazardous Drugs
Do Not Crush
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
*COVID-19 Pharmacy Resources
Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Hazardous Drugs
Do Not Crush
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
Webpage Links
Search results for:
abatacept
abatacept
Brand names:
Orencia, Orencia Prefilled Syringe
Form
Strength
ANAN
ASMP
LACH
LALK
LOHH
LOLR
LOWC
SDSD
SESE
SFSF
Formulary Status
POWDER FOR INJECTION, INTRAVENOUS
250 mg
Restricted
SOLUTION, SUBCUTANEOUS
50 mg/0.4 mL; 125 mg/mL
VIEW MORE
Disease-Modifying Antirheumatic Drugs
CLASS
923600
Comments:
Abatacept Executive Summary
Chemotherapy Chart
Last updated:
Jan. 25, 2024
Restricted:
abatacept (Orencia) is restricted to use in the Outpatient setting by Rheumatology only
CMS Self-Administered Drug Exclusion List
Orencia (subcutaneous only)
UpToDate
FDA Package Inserts
Abatacept Executive Summary
Chemotherapy Chart